Sante Ventures
Santé Ventures is a life sciences venture capital firm that invests in early-stage companies developing innovative medical technologies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sante Ventures Information
Geographic Data
Address: 201 West 5th Street
City: Austin
State: TX
Zip: 78701
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$260M
Social
Linkedin
Crunchbase
Metrics
7,861,971Website Global Rank
600Website Monthly Traffic
Twitter Followers
Description
Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $281 million in capital under management in two funds.
Contact Phone:
+15127211200
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2015 | Mirna Therapeutics | Series D | 0 |
| 7/2012 | Rex Bionics | Series A | 1M |
| 12/2015 | Molecular Templates | Series D | 4.5M |
| 4/2014 | Renascent Medical | Series A | 300k |
| 9/2014 | Molecular Templates | Series C | 3.5M |
| 10/2021 | Access Optics | Series A | 0 |
| 11/2009 | Terapio | Series A | 5M |
| 8/2010 | Explorys, Inc. | Series B | 2.5M |
| 10/2020 | KelaHealth | Seed Round | 0 |
| 1/2018 | HNI Healthcare | Series E | 0 |
| 6/2020 | Cryosa | Series A | 8.3M |
| 10/2013 | Molecular Templates | Series C | 8.5M |
| 7/2015 | Terapio | Series B | 780k |
| 8/2014 | Claret Medical | Series B | 0 |
| 6/2009 | HNI Healthcare | Series A | 3.5M |
| 1/2021 | Nirogy Therapeutics | Series A | 0 |
| 5/2016 | EndoStim | Series D | 25M |
| 6/2020 | Glyscend | Series A | 20.5M |
| 10/2015 | TVA Medical | Series C | 0 |
| 3/2009 | RiseHealth | Series A | 4M |
| 5/2011 | Explorys, Inc. | Series C | 11.5M |
| 11/2011 | HNI Healthcare | Series B | 8.4M |
| 1/2010 | TVA Medical | Series A | 2.6M |
| 12/2022 | ABK Biomedical | Series C | 0 |
| 4/2022 | Endovascular Engineering | Series A | 0 |
| 9/2021 | Cryosa | Series B | 0 |
| 11/2015 | BAROnova | Series D | 36.5M |
| 6/2013 | Healthcare Highways | Venture Round | 57k |
| 7/2008 | Zeno Corporation | Series E | 28M |
| 2/2014 | Lumos Pharma | Series A | 14M |
| 2/2015 | Lyricpharma | Series A | 20.4M |
| 6/2019 | Remedy | Series A | 10M |
| 6/2018 | Iterion Therapeutics | Series B | 2.6M |
| 6/2013 | TVA Medical | Series B | 9.5M |
| 1/2022 | Reimagine Care | Series A | 0 |
| 7/2013 | RiseHealth | Series B | 3M |
| 7/2010 | EndoStim | Series B | 6M |
| 5/2009 | Molecular Templates | Series A | 2.5M |
| 2/2015 | Laguna Pharmaceuticals | Series B | 30M |
| 6/2021 | RapidPulse | Series A | 0 |
| 8/2022 | RapidPulse | Series A | 0 |
| 3/2013 | Spinal Restoration | Series C | 5M |
| 10/2007 | Spinal Restoration | Series B | 0 |
| 9/2020 | Libra Therapeutics | Series A | 29M |
| 4/2016 | Lumos Pharma | Series B | 34M |
| 5/2023 | Surgical Safety Technologies | Series A | 0 |
| 8/2018 | Farapulse | Series B | 5M |
| 2/2016 | Farapulse | Series A | 8.6M |
| 3/2016 | Farapulse | Series A | 15M |
| 2/2013 | BAROnova | Series C | 27.3M |
| 11/2009 | Zeno Corporation | Series F | - |
| 3/2021 | Geneos Therapeutics | Series A | 12M |
| 2/2012 | AbVitro | Series A | 1.9M |
| 11/2011 | Laguna Pharmaceuticals | Series A | 1.8M |
| 12/2013 | HNI Healthcare | Series C | - |
| 3/2008 | Protein Discovery | Series C | 0 |
| 10/2013 | Ketra | Venture Round | - |
| 1/2016 | HNI Healthcare | Series D | 1.4M |
| 1/2012 | LumaTherm | Series A | 4M |
| 11/2018 | Endogenex | Series A | - |
| 8/2016 | Millipede | Series B | 6.2M |
| 2/2019 | Geneos Therapeutics | Series A | 10.5M |
| 2/2021 | Iterion Therapeutics | Series B | 17M |
| 10/2017 | Claret Medical | Series C | 0 |
| 7/2014 | Molecular Templates | Venture Round | 7M |
| 10/2022 | Sensorium Therapeutics | Series A | 0 |
| 2/2020 | BioStable | Series C | - |
| 12/2008 | BioStable | Series A | 6.3M |
| 9/2011 | Millipede | Series A | - |
| 7/2015 | Iterion Therapeutics | Series A | 1M |
| 3/2022 | Geneos Therapeutics | Series A | 0 |
| 3/2023 | Wave Life | Seed Round | 0 |
| 4/2015 | BioStable | Series B | 4.3M |
| 12/2011 | EndoStim | Venture Round | 5.5M |
| 1/2013 | EndoStim | Series C | 9.1M |
| 6/2013 | EndoStim | Series D | 14.1M |
| 9/2013 | Guided Interventions | Series A | 3.3M |
| 4/2018 | Cryosa | Series A | - |
| 10/2012 | Spinal Restoration | Venture Round | 5M |
| 5/2023 | Surgical Safety Technologies | Series A | 0 |
| 3/2023 | Wave Life | Seed Round | 0 |
| 12/2022 | ABK Biomedical | Series C | 0 |
| 10/2022 | Sensorium Therapeutics | Series A | 0 |
| 8/2022 | RapidPulse | Series A | 0 |
| 4/2022 | Endovascular Engineering | Series A | 0 |
| 3/2022 | Geneos Therapeutics | Series A | 0 |
| 1/2022 | Reimagine Care | Series A | 0 |
| 10/2021 | Access Optics | Series A | 0 |
| 9/2021 | Cryosa | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
